Newsroom

Sorted by: Latest

-

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
-

Rosen Law Firm Encourages CleanCore Solutions, Inc. Investors to Inquire About Securities Class Action Investigation – ZONE

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of CleanCore Solutions, Inc. (NYSE American: ZONE) resulting from allegations that CleanCore Solutions, Inc. may have issued materially misleading business information to the investing public. So what: If you purchased CleanCore Solutions securities you may be entitled to compensation without payment of any out of pocket fees or c...
-

Top 10 Questions State and Local Government Grants Managers Are Asking in 2026

ATLANTA & TORONTO--(BUSINESS WIRE)--What are state and local government grants managers most focused on in 2026? According to a new report from Euna Solutions, they are asking increasingly urgent questions about capacity, compliance, funding stability, manual workload, and how technology can help them keep up with growing demands. Those questions are at the center of 2026 State of Grants Management and Technology: Managing Growth Under Constraint, a new report from Euna Solutions based on insig...
-

Illinois Jury Awards Four Families $70 Million in Verdict Against Baby Formula Manufacturer

CHICAGO--(BUSINESS WIRE)--A Cook County jury has returned a verdict of $70 million including $17 million in punitive damages against Abbott Laboratories, the manufacturer of the cow’s milk-based infant feeding product Similac. The jury found that Abbott’s product caused four premature infants to develop necrotizing enterocolitis (NEC)—a crippling and often fatal intestinal disease. NEC involves the bacterial invasion of a newborn’s intestinal lining, leading to severe inflammation, tissue necro...
-

Rosen Law Firm Encourages QMMM Holdings Limited Investors to Inquire About Securities Class Action Investigation – QMMM

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of QMMM Holdings Limited (NASDAQ: QMMM) resulting from allegations that QMMM Holdings Limited may have issued materially misleading business information to the investing public. So what: If you purchased QMMM securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee...
-

Mr. Andy Cohen Elected as Director of Douglas Emmett

SANTA MONICA, Calif.--(BUSINESS WIRE)--Douglas Emmett, Inc. (NYSE:DEI), a real estate investment trust (REIT), today announced that Mr. Andy Cohen has been elected to its Board of Directors. Mr. Cohen is Global Co-Chair of Gensler, the world’s largest architecture, design and planning firm with 60 offices and 6,500 professionals across the Americas, Europe, Greater China, Asia Pacific and the Middle East. He has spent his entire 43-year career at Gensler, serving as Co-CEO from 2005 to 2024 bef...
-

Western Metallica Announces Director Appointment

TORONTO--(BUSINESS WIRE)--Western Metallica Resources Corp. (TSXV: WMS) (“Western Metallica” or the “Company”) is pleased to announce the appointment of Leanna Jokela to its board of directors effective immediately. Ms. Jokela brings over 30 years of experience in accounting and administration, with a strong reputation for supporting businesses through sound financial guidance and effective processes. Ms. Jokela’s background spans multiple industries, with a specialized expertise in government...
-

Corcept Presents Complete Data from Pivotal ROSELLA Trial in SGO Late-Breaker with Simultaneous Publication in The Lancet: Lifyorli™ (Relacorilant) Plus Nab-Paclitaxel Improves Overall Survival in Patients with Platinum-Resistant Ovarian Cancer

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today presented final overall survival data from its pivotal Phase 3 ROSELLA trial of Lifyorli™ (relacorilant) combined with the chemotherapeutic agent nab-paclitaxel in patients with platinum-resis...
-

U.S. Rep. Ryan Mackenzie and Allentown Community Celebrate $2.7 Million in FHLBank Pittsburgh Affordable Housing Grants

ALLENTOWN, Pa.--(BUSINESS WIRE)--U.S. Rep Mackenzie joined FHLBank and Allentown locals to tour Blueprint Communities projects and celebrate $2.7M affordable housing grants....
-

The Journey Begins: Union Pacific’s Famed Big Boy Kicks Off America 250 Tour from Historic Transcontinental Site

OMAHA, Neb.--(BUSINESS WIRE)--Union Pacific’s legendary Big Boy No. 4014 steam locomotive embarked on its first coast-to-coast tour today in celebration of America’s 250th anniversary with a kickoff ceremony held at Milepost 0 in downtown, Sacramento – the historic site where Central Pacific Railroad began construction on the first transcontinental railroad line in 1863. Union Pacific CEO Jim Vena was joined during the celebratory send-off by Toks Omishakin, secretary of California’s State Tran...